SCHEMBL20099871

SCHEMBL20099871

COc1cccc(CCCCO)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.46
LIPG Q9Y5X9 1/20 0.43
MAOA P21397 2/20 0.40
KDM1A O60341 1/20 0.40
MAOB P27338 1/20 0.40
CYP4F2 P78329 2/20 0.39
CYP4A11 Q02928 2/20 0.39
LMNA P02545 1/20 0.38
PGR P06401 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
MAPT P10636 1/20 0.38
CYP2C9 P11712 1/20 0.38
TBXA2R P21731 1/20 0.38
MAPK1 P28482 1/20 0.38
AVPR2 P30518 1/20 0.38
CYP2C19 P33261 1/20 0.38
HTR2B P41595 1/20 0.38
HTT P42858 1/20 0.38
PDE3A Q14432 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23888634 0.95 LIPG (0.44) KCNH2LIPGMAOAKDM1AMAOB
SCHEMBL932468 0.87 KDM1A (0.42) KCNH2LIPGMAOAKDM1AMAOB
SCHEMBL8241098 0.83 KCNH2 (0.46) KCNH2LIPGMAOAKDM1AMAOB
SCHEMBL21706158 0.83 KCNH2 (0.70) KCNH2LIPGMAOAKDM1AMAOB
SCHEMBL24261314 0.83 KCNH2 (0.70) KCNH2LIPGMAOAKDM1AMAOB
SCHEMBL27916483 0.82 KCNH2 (0.58) KCNH2LIPGMAOAKDM1AMAOB
SCHEMBL2567286 0.81 KCNH2 (0.59) KCNH2CYP4F2CYP4A11MAPT
SCHEMBL19542 0.80 KDM1A (0.44) LIPGMAOAKDM1AMAOBTDP1
SCHEMBL15677623 0.78 KCNH2 (0.47) KCNH2LIPGMAOAKDM1AMAOB
SCHEMBL29792045 0.77 MPO (0.43) KCNH2LIPGMAOAKDM1AMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3315492-B1 PYRAZOLE DERIVATIVE, OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF KISSEI PHARMACEUTICAL (JP) 2020-09-16 EP disclosed
EP-3315492-A1 PYRAZOLE DERIVATIVE, OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Kissei Pharmaceutical Co., Ltd. (JP) 2018-05-02 EP disclosed